You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Subconjunctival Bevacizumab

Showing 1 - 25 of 2,269
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pterygium of Conjunctiva and Cornea Trial (5-Fluorouracil, Bevacizumab, Normal saline)

Withdrawn
  • Pterygium of Conjunctiva and Cornea
  • (no location specified)
Aug 5, 2021

Intravitreal Injection, Pain, Subconjunctival Hemorrhage Trial in Holon (Cooled eye drops and povidone-iodine)

Completed
  • Intravitreal Injection
  • +2 more
  • Cooled eye drops and povidone-iodine
  • Holon, Hamerkaz, Israel
    Wolfson Medical Center
Dec 28, 2021

Pterygium Trial in Ariana (Preoperative Intra-lesional Bevacizumab Injection in primary pterygium, pterygium surgery without

Completed
  • Pterygium
  • Preoperative Intra-lesional Bevacizumab Injection in primary pterygium
  • pterygium surgery without adjunctive therapy
  • Ariana, Illinois, Tunisia
    Dhouha Gouider
Apr 3, 2022

Corneal Newvessels Trial in France (bevacizumab, NaCl)

Completed
  • Corneal Newvessels
  • Limoges, France
  • +4 more
Oct 23, 2019

Glaucoma Trial in London (bevacizumab, 5-fluorouracil, Dexamethasone)

Completed
  • Glaucoma
  • London, United Kingdom
    Moorfields Eye Hospital, Clinical Research Facility
Aug 16, 2021

Irvine-Gass Syndrome Trial in Boston (Aflibercept)

Terminated
  • Irvine-Gass Syndrome
  • Boston, Massachusetts
    Tufts Medical Center
Aug 19, 2020

Aqueous Humor Drainage Trial in Mbour (eyeTube)

Active, not recruiting
  • Aqueous Humor Drainage
  • eyeTube
  • Mbour, Senegal
    Senghor Centre
Jun 12, 2023

Pterygium Trial (OPHTESIC LIDOCAINE HYDROCHLORIDE 20MG/G, Xylocaine with Epinephrine)

Not yet recruiting
  • Pterygium
  • OPHTESIC LIDOCAINE HYDROCHLORIDE 20MG/G
  • Xylocaine with Epinephrine
  • (no location specified)
Jul 30, 2023

Corneal Ulcer Trial in Chicago (Mesenchymal Stromal Cells, Control Solution)

Not yet recruiting
  • Corneal Ulcer
  • Mesenchymal Stromal Cells
  • Control Solution
  • Chicago, Illinois
    Department of Ophthalmology and Visual Sciences
Jan 21, 2023

Cataract, Ocular Inflammation, Ocular Hypertension Trial (Intraoperative delivery of medication, Kenalog (Triamcinolone),

Not yet recruiting
  • Cataract
  • +3 more
  • Intraoperative delivery of medication, Kenalog (Triamcinolone)
  • Topical post-operative eyedrops, Prednisolone acetate
  • (no location specified)
Aug 4, 2022

Hepatocellular Carcinoma Trial in Guangzhou (Candonilimab, Bevacizumab)

Withdrawn
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
Jun 1, 2023

Patients With HHT. Follow up BABH

Completed
  • Hemorrhagic Hereditary Telangiectasia
  • HHT
  • bevacizumab treatment
  • Angers, France
  • +2 more
Sep 8, 2023

Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatocellular Carcinoma Non-resectable Trial in Seoul (Atezolizumab plus

Recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Atezolizumab plus bevacizumab, combined EBRT to vascular invasion
  • Atezolizumab plus bevacizumab
  • Seoul, Korea, Republic of
    Asan Medical Center
Aug 7, 2023

Brain Metastases Trial (Gamma Tile-Surgically Targeted Radiation Therapy (STaRT), Stereotactic Radiation Therapy)

Not yet recruiting
  • Brain Metastases
  • Gamma Tile-Surgically Targeted Radiation Therapy (STaRT)
  • Stereotactic Radiation Therapy
  • (no location specified)
Jun 2, 2023

Glioblastoma Trial (plasma collection)

Not yet recruiting
  • Glioblastoma
  • plasma collection
  • (no location specified)
Aug 18, 2023

Hepatocellular Carcinoma Trial in Nanjing, Shanghai (QL1706, Bevacizumab, Oxaliplatin injection)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Nanjing, Jiangsu, China
  • +1 more
Jul 28, 2023

Hepatocellular Carcinoma Trial in Guangzhou (Candonilimab, Bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
Feb 26, 2023

Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, High Grade Endometrioid Ovarian Cancer Trial in Guangzhou (Fluzoparib

Not yet recruiting
  • Ovarian Cancer
  • +4 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Cetntre
Sep 25, 2023

Colorectal Cancer Trial (HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab, HR070803 simulator plus oxaliplatin, 5-FU/LV,

Not yet recruiting
  • Colorectal Cancer
  • HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab
  • HR070803 simulator plus oxaliplatin, 5-FU/LV, bevacizumab
  • (no location specified)
Jul 13, 2023

Ovarian Cancer, Carcinoma, Ovarian Epithelial, Fallopian Tube Tumors Trial in Worldwide (biological, drug, other)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Pembrolizumab
  • +4 more
  • Phoenix, Arizona
  • +178 more
Jan 25, 2023

89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

Recruiting
  • Neurofibromatosis 2
  • Bevacizumab Zirconium Zr-89
  • Leiden, Zuid-Holland, Netherlands
    Leiden University Medical Center
Jan 5, 2023

Metastatic Microsatellite-stable Colorectal Cancer Trial in China (Experimental drug, Control Rx)

Recruiting
  • Metastatic Microsatellite-stable Colorectal Cancer
  • Experimental drug
  • Control Rx
  • Hefei, Anhui, China
  • +11 more
Mar 13, 2023

Carcinoma, Ovarian Epithelial Trial in San Fermo Della Battaglia, Padova (Olaparib, Bevacizumab)

Recruiting
  • Carcinoma, Ovarian Epithelial
  • San Fermo Della Battaglia, Como, Italy
  • +1 more
Nov 2, 2023

Cervical Cancer Trial in Wuhan (Recombinant humanized anti-PD-1 mAb injection, Cisplatin, Bevacizumab Injection)

Not yet recruiting
  • Cervical Cancer
  • Recombinant humanized anti-PD-1 monoclonal antibody injection
  • +4 more
  • Wuhan, Hubei, China
    Tongji Hospital affiliated to Tongji Medical College of Huazhong
Nov 3, 2023

Metastatic Colorectal Cancer, CRC, KRAS/NRAS Mutation Trial (Onvansertib, FOLFIRI, Bevacizumab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • +2 more
  • (no location specified)
Oct 24, 2023